Concepedia

S. Lovell

SL

16

Publications

620

Citations

14

H-Index

1999

Active since

Affiliations

Stanford University(Current)

Imperial College London

German Cancer Research Center

Heidelberg University

Translational Research Institute

S. Lovell is an author at Stanford University specializing in natural sciences, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1999–2025

16

Publications

16

Identification of highly selective covalent inhibitors by phage display

Shiyu Chen, S. Lovell, Sumin Lee et al. · Nature Biotechnology · 2020 · 132 citations · Full text

, , +6

Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19

Kas Steuten, Heeyoung Kim, John C. Widen et al. · ACS Infectious Diseases · 2021 · 100 citations · Full text

Faecal neutrophil elastase-antiprotease balance reflects colitis severity

Rachael Barry, David Ruano‐Gallego, Shiva T. Radhakrishnan et al. · Mucosal Immunology · 2019 · 56 citations · Full text

, , +10

Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer

Bruno M. Simões, Angélica Santiago-Gómez, Chiara Chiodo et al. · Oncogene · 2020 · 46 citations · Full text

Characterization of the Bacterioferritin/Bacterioferritin Associated Ferredoxin Protein–Protein Interaction in Solution and Determination of Binding Energy Hot Spots

Yan Wang, Huili Yao, Yuan Cheng et al. · Biochemistry · 2015 · 43 citations · Full text

Rows per page

1–5 of 16